Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03478826 · ClinicalTrials.gov registry record

Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

A clinical trial of Interstitial Lung Disease, sponsored by Mayo Clinic.

Recruiting
Registry status
635
Enrollment target
1
Study location

NCT03478826 is a study of Interstitial Lung Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 635 participants, above the 549-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (16% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03478826, a study of Interstitial Lung Disease, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
635 participants
Enrollment target
1
Study location

Study Summary

To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.

Conditions Studied

Interstitial Lung Disease

Interventions

  • OTHER ILD
  • OTHER Healthy
  • OTHER Pneumonia

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 635 participants
Start Date 2018-08-01
Est. Completion 2028-01

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03478826

The ClinicalTrials.gov registry entry for NCT03478826 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 635 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 549-participant average among 36 other Interstitial Lung Disease trials with a reported enrollment target (16% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Interstitial Lung Disease appearing as the primary indexed condition, and to 3 interventions - of which ILD is the first listed.

NCT03478826 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03478826 about?

NCT03478826 is a clinical study titled "Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)". To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.

What is the current status of trial NCT03478826?

This trial is currently recruiting. The enrollment target is 635 participants. The study started on 2018-08-01. Estimated completion is 2028-01.

What conditions does trial NCT03478826 study?

This clinical trial studies the following conditions: Interstitial Lung Disease.

What interventions are being tested in trial NCT03478826?

The interventions under investigation include: ILD (OTHER), Healthy (OTHER), Pneumonia (OTHER).

Who is sponsoring clinical trial NCT03478826?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03478826 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Interstitial Lung Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Interstitial Lung Disease

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.